Qube Research & Technologies LTD Avita Medical, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.45 - $14.48 $215,907 - $484,703	33,474 Added 148.34%	56,039 $782,000
Q4 2022 Feb 14, 2023	BUY	$4.53 - $7.55 $20,208 - $33,680	4,461 Added 24.64%	22,565 $148,000
Q3 2022 Nov 14, 2022	SELL	$4.97 - $7.89 $19,626 - $31,157	-3,949 Reduced 17.91%	18,104 $95,000
Q2 2022 Aug 15, 2022	BUY	$4.6 - $8.82 $101,443 - $194,507	22,053 New	22,053 $105,000
Q2 2021 Aug 13, 2021	SELL	$17.23 - $22.02 $392,775 - $501,967	-22,796 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$18.38 - $28.41 $731,064 - $1.13 Million	-39,775 Reduced 63.57%	22,796 $452,000
Q4 2020 Feb 16, 2021	BUY	$17.55 - $27.2 $1.1 Million - $1.7 Million	62,571 New	62,571 $1.16 Million

5.96M

35.5K

38K

Ticker RCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,030,900
Market Cap $287M
Description
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.